K2 BioCapital
Building Cross Border Biotech
Venture Architect and strategic advisory for global biotech companies seeking cross-border opportunities between Asia and Western markets.
What We Do
Venture Architecture
We design and develop emerging biotech companies from the ground up based around promising assets, crafting their go-to-market strategies and building sustainable business models that attract global investors.
Cross-Border Dealmaking
Our expertise bridges Asia and global markets through licensing agreements, joint venture formation, and market entry strategies that unlock value across borders.
Fractional Leadership
We provide C-suite leadership (CBO/CEO) for early and mid-stage biotech ventures, delivering executive expertise without the full-time overhead during critical growth phases.
Family Office/VC Consulting
We guide investment strategies for family offices and VC funds seeking cross-border biotech opportunities, ensuring investor readiness and access to vetted opportunities.
Our Strategic Perspective
1
Cross-Border Capital: The Next Frontier
China has transformed global biotech. The future belongs to those who can successfully tap into and commercialize this innovation across borders.
2
Licensing Arbitrage Opportunity
Chinese assets remain undervalued abroad. Western entities seek access but lack local pathways. Our embedded position in local ecosystems provides the bridge.
3
High-Caliber BD for Early-Stage Founders
In tight capital markets, founders cannot afford to miss opportunities. We step in as fractional executives, guiding licensing, GTM, and capital strategy during critical growth phases.
4
Family Office & VC Infrastructure
Significant capital seeks cross-border biotech opportunities but lacks proper infrastructure. We help funds source, vet, and structure cross-border deals with clarity and confidence.
Global Footprint
Asia
Strong established relationships across China's biotech hubs, Singapore's innovation ecosystem, and Japan's pharmaceutical industry. We navigate local regulatory environments and cultural nuances.
United States
Extensive investor and operator network spanning Boston, San Francisco, and emerging biotech clusters. Deep connections with research institutions and venture capital firms.
UK & EU
Cross-cultural fluency and established business development partnerships across key European biotech hubs, enabling seamless market entry and collaboration opportunities.
Who We Serve
Biotech Founders
- Fractional CEO/CBO leadership
- Go-to-market strategy development
- Licensing negotiation and support
- U.S. market entry facilitation
- Fundraising strategy and investor connections
VC Funds
- New company formation and incubation
- Portfolio BD acceleration
- Cross-border co-investment opportunities
- Market intelligence and trend analysis
- Deal structuring and negotiation support
Family Offices
- Vetted biotech investment opportunities
- Comprehensive due diligence support
- Biotech ecosystem navigation
- Portfolio company management
- Long-term value creation strategies
Meet Our Founder
Irtaza Haider
A seasoned biotech strategist, operator, and venture architect with a proven track record of success:
- Successfully exited two startups as an operator
- Biotech VC background (OMX Ventures, Transform VC)
- Technology transfer experience at Northwestern University
- Global Executive MBA from Kellogg School of Management
- Joint partnership with HKUST and PKU-Guanghua
Combining deep industry knowledge with cross-cultural expertise to bridge biotech innovation across borders.
Ready to Cross Borders and Build Biotech?
Contact K2 BioCapital
Let's discuss how our strategic advisory services can help you navigate the complex landscape of global biotech opportunities.
Discover how we can help you capitalize on cross-border biotech opportunities and accelerate your global growth strategy.